Genetic Test Could Match Prostate Patients to New Treatment

Scientists at MD Anderson have discovered two genetic markers that predict which prostate cancer patients will respond to an emerging therapy called ferroptosis.

The breakthrough could help doctors quickly match resistant cancers to the right treatment.